Recruiting

Observational Study

Sponsor:

xCures

Code:

NCT03793088

Conditions

Oncology

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

XCELSIOR is a non-interventional data registry. Information about treatments, treatment decisions and rationale, and patient outcomes including safety and effectiveness of anti-cancer therapy and associated supportive care will be collected for analysis.

Conditions

Oncology

Study ID

NCT03793088

Start date

Feb 7, 2019

Status verified date

Jan, 2023

Completion date

Jan, 2026

Anticipated

Primary completion date

Jan, 2024

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Both male and female patients with known or suspected recalcitrant or advanced cancer are eligible to enroll through the Cancer Commons Website
  • Patients with any performance status, comorbidity or disease severity are eligible
  • Patients or their legally-authorized representative must be willing and able to provide written, informed consent (and assent, if applicable)

Exclusion Criteria:

  • Patients must be a resident of or receiving care within the United States or US territories.

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Progression Free Survival (PFS) [ Time Frame: 5 Years ]
  • Overall Survival (OS) [ Time Frame: 5 years ]

Central Contacts and Locations

Central contacts

Bryan J Federowicz

707-641-4475bfederowicz@xcures.com

Locations

Cancer Commons

Recruiting

Los Altos, California, United States, 94022

More Information

Sponsor

xCures

Last update posted

Feb 3, 2023

Last verified

Jan, 2023

Keywords

  • Glioblastoma
  • Glioma
  • Pancreatic Adenocarcinoma

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by xCures on 2023-02-03.